Blog
About

11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.

      The Febs Journal

      enzymology, drug effects, West Nile virus, Virus Replication, metabolism, genetics, chemistry, Viral Nonstructural Proteins, Protein Conformation, Protein Binding, pharmacology, Protease Inhibitors, Polymorphism, Single Nucleotide, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Kinetics, Endopeptidases, Crystallography, X-Ray, Binding Sites, Amino Acid Substitution, Amino Acid Sequence

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The two-component NS2B-NS3 protease of West Nile virus is essential for its replication and presents an attractive target for drug development. Here, we describe protocols for the high-yield expression of stable isotope-labelled samples in vivo and in vitro. We also describe the use of NMR spectroscopy to determine the binding mode of new low molecular mass inhibitors of the West Nile virus NS2B-NS3 protease which were discovered using high-throughput in vitro screening. Binding to the substrate-binding sites S1 and S3 is confirmed by intermolecular NOEs and comparison with the binding mode of a previously identified low molecular mass inhibitor. Our results show that all these inhibitors act by occupying the substrate-binding site of the protease rather than by an allosteric mechanism. In addition, the NS2B polypeptide chain was found to be positioned near the substrate-binding site, as observed previously in crystal structures of the protease in complex with peptide inhibitors or bovine pancreatic trypsin inhibitor. This indicates that the new low molecular mass compounds, although inhibiting the protease, also promote the proteolytically active conformation of NS2B, which is very different from the crystal structure of the protein without inhibitor.

          Related collections

          Author and article information

          Journal
          19583774
          10.1111/j.1742-4658.2009.07132.x

          Comments

          Comment on this article